ORCL

Oracle
D

ORCL

Arincen58/100B
123.790
USD
-2.43
(-1.92%)
Pre Open·122.000USD-1.790(-1.45%)
Last updated: · Delayed 15 min
Fair value235.44Plus-47%177Price 123.79294
Q2 FY2027 · Earnings report
EPS estimate 1.88Revenue estimate 21.33B
OverviewFinancialsSignalsNewsForecastEarningsDividendsCompany

Oracle net income 1986–2027

Oracle earned 4.76B USD in Q1 FY2027, the three months to 31 August 2026, up 62.6% on the same quarter a year before. Oracle's net income over the last twelve months was 18.92B USD, up 52.1% on the twelve months before. In fiscal year 2026 it earned 17.09B USD, up 37.3% on the year before.

Last updated 3 Nov 2026 · Next report 14 Dec 2026

Net income

Net income · +6.7% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM31 Aug 202618.92B+52.08%26.36%71.78B
FY202631 May 202617.09B+37.32%25.37%67.36B
FY202531 May 202512.44B+18.88%21.68%57.40B
FY202431 May 202410.47B+23.10%19.76%52.96B
FY202331 May 20238.50B+26.59%17.02%49.95B
FY202231 May 20226.72B-51.13%15.83%42.44B
FY202131 May 202113.75B+35.63%33.96%40.48B
FY202031 May 202010.14B-8.55%25.94%39.07B
FY201931 May 201911.08B+208.98%28.05%39.51B
FY201831 May 20183.59B-62.05%9.01%39.83B
FY201731 May 20179.45B+6.19%25.05%37.73B
FY201631 May 20168.90B-10.43%24.03%37.05B
FY201531 May 20159.94B-9.28%26.00%38.23B
FY201431 May 201410.96B+0.27%28.62%38.28B
FY201331 May 201310.93B+9.46%29.38%37.18B
FY201231 May 20129.98B+16.78%26.89%37.12B
FY201131 May 20118.55B+39.32%23.99%35.62B
FY201031 May 20106.14B+9.69%22.87%26.82B
FY200931 May 20095.59B+1.30%24.05%23.25B
FY200831 May 20085.52B+29.18%24.61%22.43B
FY200731 May 20074.27B+26.41%23.75%18.00B
FY200631 May 20063.38B+17.15%23.51%14.38B
FY200531 May 20052.89B+7.65%24.46%11.80B
FY200431 May 20042.68B+16.21%26.40%10.16B
FY200331 May 20032.31B+3.73%24.35%9.48B
FY200231 May 20022.22B-13.16%22.99%9.67B
FY200131 May 20012.56B-59.33%23.58%10.86B
FY200031 May 20006.30B+388.22%62.16%10.13B
FY199931 May 19991.29B+58.51%14.61%8.83B
FY199831 May 1998813.70M-0.94%11.39%7.14B
FY199731 May 1997821.46M+36.17%14.45%5.68B
FY199631 May 1996603.28M+36.64%14.28%4.22B
FY199531 May 1995441.50M+55.62%14.88%2.97B
FY199431 May 1994283.70M+188.90%14.18%2.00B
FY199331 May 199398.20M+59.67%6.53%1.50B
FY199231 May 199261.50M—5.22%1.18B
FY199131 May 1991-12.40M-110.56%-1.21%1.03B
FY199031 May 1990117.40M+43.52%12.09%970.80M
FY198931 May 198981.80M+90.68%14.01%583.70M
FY198831 May 198842.90M+175.00%15.21%282.10M
FY198731 May 198715.60M+164.41%11.88%131.30M
FY198631 May 19865.90M—10.65%55.40M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Oracle's profit

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.